Don’t Trade in the Dark—Get Your Pre-Market Report Every Day.Join Now
Run a search on a company

Lupin Ltd

Healthcare | Large Cap

Lupin Ltd Health Insights
Health Score : 7.84Health Score : 7.84

Lupin Ltd demonstrates a very strong financial profile, marked by exceptional growth and profitability. The company is rapidly expanding its sales and profits, indicating strong market demand and effective business strategies. Its financial foundation is solid, with very low levels of debt, which minimizes long-term risk and provides stability. Shareholders are seeing excellent returns, and the company has no trouble covering its financial obligations. The primary area of concern is in operational efficiency. The company appears to be slow in selling its inventory and collecting payments from customers. While its strong growth is currently a major positive, these inefficiencies in managing day-to-day operations could present challenges in the future. The outlook is positive, driven by its powerful growth engine, but sustained success will depend on how it manages its operational assets.

Latest Report

View All

The Latest Reports Are Not Available at the Moment. We’ll Notify You Once They’re Available.


Latest News

View All

The Latest News Is Not Available at the Moment. We’ll Notify You Once It’s Available.

Overview
Ratio
Financial
Lupin Ltd Health Insights
Health Score : 7.84Health Score : 7.84

Lupin Ltd demonstrates a very strong financial profile, marked by exceptional growth and profitability. The company is rapidly expanding its sales and profits, indicating strong market demand and effective business strategies. Its financial foundation is solid, with very low levels of debt, which minimizes long-term risk and provides stability. Shareholders are seeing excellent returns, and the company has no trouble covering its financial obligations. The primary area of concern is in operational efficiency. The company appears to be slow in selling its inventory and collecting payments from customers. While its strong growth is currently a major positive, these inefficiencies in managing day-to-day operations could present challenges in the future. The outlook is positive, driven by its powerful growth engine, but sustained success will depend on how it manages its operational assets.

Latest Report

View All

The Latest Reports Are Not Available at the Moment. We’ll Notify You Once They’re Available.


Latest News

View All

The Latest News Is Not Available at the Moment. We’ll Notify You Once It’s Available.

Neutral

Overall Valuation Score

Highly Undervalued
Undervalued
Neutral
Overvalued
Highly Overvalued
Neutral

P/E RATIO (TTM)

16.89

Undervalued

Industry Median

28.62

Undervalued
Undervalued

Large Cap Median

30.25

Undervalued

P/E RATIO

20.16

P/B RATIO

4.79

Overvalued

Industry Median

3.17

Overvalued
Neutral

Large Cap Median

5.04

Neutral

P/S RATIO

3.83

Neutral

Industry Median

3.42

Neutral
Undervalued

Large Cap Median

5.48

Undervalued

Others

Neutral

PEG RATIO

0.00

Neutral
Neutral

EV/EBITDA RATIO

11.96

Neutral

The Calculations Shown Above Are Based on the Last Traded Price (LTP) of ₹2351.6 as on Jun 20, 2026.

Markets Depth NSE

Buy Orders

  1. Bid

    Quantity

    Orders

  2. No buy depth

  3. Total

    0

    0

Sell Orders

  1. Ask

    Quantity

    Orders

  2. No sell depth

  3. Total

    0

    0

BidsOffers
50.00%50.00%

Markets Today NSE

  1. High

    0.00

  2. Low

    0.00

  3. Open

    0.00

  4. Close

    0.00

  5. Prev Close

    0.00

  6. Avg Price

    0.00

  7. Volume

    0

  8. Last Traded Quantity

    0

  9. Last Traded Time

    N/A

Price Movement Indicator

0.00

0.00
Today's Low

0.00
Today's High

Growth Ratio Summary
Growth Ratio SummaryGrowth Score : 10.00

The company is demonstrating outstanding performance in terms of growth. All key indicators, including revenue, operating profit, and earnings per share, are expanding at an exceptional rate. This rapid expansion is supported by significant growth in the company's asset base. Such strong, across-the-board growth points to successful business strategies, high market demand, and a very positive outlook for continued expansion and shareholder value creation.

ExcellentRevenue Growth RateExcellent
ExcellentOperating Profit Growth RateExcellent
ExcellentEarnings Per Share (EPS) GrowthExcellent
ExcellentAsset Growth RateExcellent
ExcellentNet Income Growth RateExcellent
Growth RatiosMar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Revenue Growth Rate8.191.4420.2413.4823.12
Operating Profit Growth Rate-91.47685.84120.838.8967.03
Earnings Per Share (EPS) Growth-225.4-128.11344.5571.162.28
Asset Growth Rate-7.595.314.1722.0132.39
Net Income Growth Rate-224.43-129.32332.1470.7661.98
01.

Revenue Growth Rate

02.

Operating Profit Growth Rate

03.

Earnings Per Share (EPS) Growth

04.

Asset Growth Rate

05.

Net Income Growth Rate

Financial Ratio Summary
Financial Ratio SummaryFinancial Score : 8.40

The company demonstrates strong financial health from a shareholder's viewpoint. Key performance indicators such as earnings per share and book value are growing robustly, indicating an increase in shareholder wealth. Dividend payments are also strong and well-supported. The company is making significant investments in capital assets, which, while representing a large cash outflow, is likely a strategic move to fuel its impressive growth and secure its future market position.

ExcellentAdjusted Earnings Per Share (Adjusted EPS)Excellent
ExcellentCash Earnings Per Share (Cash EPS)Excellent
ExcellentBook Value Per ShareExcellent
ExcellentDividend Per Share (DPS)Excellent
PoorCapital Expenditures (CapEx)Poor
Financial RatiosMar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Adjusted Earnings Per Share (Adjusted EPS)-34.319.842.5172.46127.74
Cash Earnings Per Share (Cash EPS)2.8829.2168.8698.35147.93
Book Value Per Share267.1273.96314.07378.09493.36
Dividend Per Share (DPS)4.033.977.9812.2217.5
Capital Expenditures (CapEx)898146191716531807
01.

Adjusted Earnings Per Share (Adjusted EPS)

02.

Cash Earnings Per Share (Cash EPS)

03.

Book Value Per Share

04.

Dividend Per Share (DPS)

05.

Capital Expenditures (CapEx)

Profitability Ratio Summary
Profitability Ratio SummaryProfitability Score : 10.00

The company's profitability is outstanding across the board. It is highly effective at converting revenue into profit at every stage, from production to the final bottom line. The returns it generates on its assets, shareholders' equity, and the total capital it uses are all exceptional. This indicates superior management, strong pricing power, and a highly efficient business model within its industry.

ExcellentGross Profit MarginExcellent
ExcellentReturn on Capital Employed (ROCE)Excellent
ExcellentReturn on Equity (ROE)Excellent
ExcellentReturn on Assets (ROA)Excellent
ExcellentOperating MarginExcellent
ExcellentNet MarginExcellent
Profitability RatiosMar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Gross Profit Margin-8.785.0513.0118.0926.61
Return on Capital Employed (ROCE)-76162130
Return on Equity (ROE)-12.573.5913.5519.2223.86
Return on Assets (ROA)1.017.551618.2122.98
Operating Margin1.3310.3418.9923.2431.53
Net Margin-9.312.699.6714.5619.15
01.

Gross Profit Margin

02.

Return on Capital Employed (ROCE)

03.

Return on Equity (ROE)

04.

Return on Assets (ROA)

05.

Operating Margin

06.

Net Margin

Efficiency Ratio Summary
Efficiency Ratio SummaryEfficiency Score : 2.67

The company's operational efficiency is a notable area of concern. It appears to face challenges in how quickly it sells its products and collects payments from customers. Furthermore, the analysis suggests that the company is not generating a high level of sales relative to the size of its assets, including fixed assets and total capital. This indicates that its resources may not be utilized to their full potential, which can impact overall performance.

PoorFixed Asset Turnover RatioPoor
WeakInventory Turnover RatioWeak
WeakReceivables Turnover RatioWeak
PoorDays Sales in Inventory RatioPoor
PoorReceivable DaysPoor
PoorCapital Turnover RatioPoor
Efficiency RatiosMar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Fixed Asset Turnover Ratio2.221.992.252.342.47
Inventory Turnover Ratio4.093.463.693.573.55
Receivables Turnover Ratio3.763.814.364.464.62
Days Sales in Inventory Ratio89.24105.4998.92102.24102.82
Receivable Days97.0795.883.7281.8479
Capital Turnover Ratio1.31.31.381.171.13
01.

Fixed Asset Turnover Ratio

02.

Inventory Turnover Ratio

03.

Receivables Turnover Ratio

04.

Days Sales in Inventory Ratio

05.

Receivable Days

06.

Capital Turnover Ratio

Coverage Ratio Summary
Coverage Ratio SummaryCoverage Score : 10.00

The company's capacity to meet its financial obligations is excellent. It generates a very high level of earnings compared to its interest expenses, indicating a very low risk of default. Additionally, its profits provide a strong and secure backing for its dividend payments to shareholders. This high level of coverage provides significant financial security and confidence for both lenders and investors.

ExcellentInterest Coverage RatioExcellent
ExcellentEquity Dividend Coverage RatioExcellent
Coverage RatiosMar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Interest Coverage Ratio-8.593.618.7614.6116.84
Equity Dividend Coverage Ratio2.385.265.886.67
01.

Interest Coverage Ratio

02.

Equity Dividend Coverage Ratio

Solvency Ratio Summary
Solvency Ratio SummarySolvency Score : 10.00

The company exhibits an exceptionally strong and stable financial structure. Its reliance on debt is minimal, with the vast majority of its operations funded by its own capital. This low-risk approach to financing makes the company highly resilient to economic shifts and interest rate changes. This robust solvency provides a secure foundation for long-term sustainability and future investments.

ExcellentDebt RatioExcellent
ExcellentDebt to Equity RatioExcellent
ExcellentEquity RatioExcellent
ExcellentDebt To Asset RatioExcellent
Solvency RatiosMar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debt Ratio0.040.030.020.110.09
Debt to Equity Ratio0.040.030.020.120.1
Equity Ratio0.960.970.980.890.91
Debt To Asset Ratio0.020.010.010.070.06
01.

Debt Ratio

02.

Debt to Equity Ratio

03.

Equity Ratio

04.

Debt To Asset Ratio

Liquidity Ratio Summary
Liquidity Ratio SummaryLiquidity Score : 6.28

The company's ability to cover its short-term debts is adequate. It holds a reasonable amount of current assets to meet immediate obligations, and its position is particularly good when excluding less-liquid inventory. However, its cash generation from core business operations appears somewhat constrained relative to its short-term liabilities. This indicates a stable but not exceptionally strong liquidity position, suggesting a balanced approach to managing its working capital.

AverageCurrent RatioAverage
GoodQuick RatioGood
AverageCash RatioAverage
WeakOperating Cash Flow RatioWeak
Liquidity RatiosMar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Current Ratio1.351.271.411.831.67
Quick Ratio0.840.820.881.261.22
Cash Ratio0.120.130.130.330.42
Operating Cash Flow Ratio0.040.190.40.310.54
01.

Current Ratio

02.

Quick Ratio

03.

Cash Ratio

04.

Operating Cash Flow Ratio

Peer Comparison With 10 Companies

Peer Comparison empowers investors to evaluate a company against its industry peers using key financial metrics like P/E ratio, EPS, and profit margins. It helps identify whether a company is overvalued, undervalued, or performing in line with competitors. Investors can use this data to spot opportunities, assess risks, and make informed decisions. This contextual view adds depth beyond standalone company analysis.

NO Company Name Health Score P/E Ratio Valuation OPM EPS Latest Profit & Loss
1Abbott India Ltd8.6835.89Neutral1892.00730.391552.00
2Glaxosmithkline Pharmaceuticals Ltd8.3838.14Neutral1309.0059.731036.00
3Alkem Laboratories Ltd8.0827.91Neutral3005.00182.762351.00
4Lupin Ltd7.8420.16Neutral8816.00139.255355.00
5Cipla Ltd7.6228.15Neutral5883.0043.523862.00
6Mankind Pharma Ltd7.6152.10Highly Overvalued3617.0049.341938.00
7Zydus Lifesciences Ltd7.6021.38Neutral8475.0035.385124.00
8Laurus Labs Ltd7.1085.84Neutral1778.0013.72890.00
9Dr Reddys Laboratories Ltd6.4925.31Neutral6454.0038.584158.00
10Glenmark Pharmaceuticals Ltd6.3645.87Neutral4572.00-7.121362.00
Management Assessment Summary
GreenStrong Management

Management effectiveness is rated Green due to a significant and broad-based business turnaround. After a period of weak performance, including a net loss in FY22, the company has demonstrated a strong recovery in FY24. This is evidenced by accelerating sales and profit growth, substantial margin expansion from 10% to 19% (OPM), and a sharp improvement in capital efficiency metrics like ROCE (6% to 16%). Financial prudence is reflected in the reduction of debt, leading to a low debt-to-equity ratio of 0.20. This operational and financial turnaround has been recognized by institutional investors, with a notable increase in FII holdings. The primary weakness remains the historical volatility of earnings, but the current positive momentum indicates effective management execution.

Category Metric Value Assessment
PROS Strong Profit Growth 3Y CAGR: 141% Outstanding
PROS Improving Operating Margins 19% (FY24) vs 10% (FY23) Strong
PROS Improving Capital Efficiency ROCE: 16% (FY24) vs 6% (FY23) Excellent
PROS Prudent Debt Management Debt/Equity: 0.20 Very Strong
PROS Increasing Institutional Holding FIIs: 18.29% vs 13.32% (YoY) Improving
CONS Inconsistent Historical Earnings Net Loss in FY22 Volatile
CONS Volatile Dividend Payout -12% (FY22) vs 19% (FY24) Inconsistent
GoodFinancial Performance & GrowthGood
ExcellentCapital Efficiency & ReturnsExcellent
ExcellentFinancial Health & PrudenceExcellent
GoodShareholding & Ownership StructureGood
01.

Financial Performance & Growth

02.

Capital Efficiency & Returns

03.

Financial Health & Prudence

04.

Shareholding & Ownership Structure

Risk Assessment Summary
OrangeBalanced Risk

The primary risk factor is the significant historical volatility in the company's earnings. The financial data reveals a cycle of strong performance followed by sharp downturns, exemplified by the substantial net loss recorded in FY22, which was preceded and followed by periods of profitability. This pattern suggests the business is exposed to operational or market risks that can drastically impact the bottom line. While the current financial turnaround is very strong and multiple metrics are improving, the historical precedent of volatility cannot be overlooked. This inherent instability in past earnings presents a notable risk to future financial predictability.

AverageEarnings Quality & VolatilityAverage
01.

Earnings Quality & Volatility

0 Credits RemainingUnlock Deep Technical Insights in Seconds Only with Dhanarthi AI

Overall Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bullish

Market Sentiment

Analysis Driven By 26 Technical Indicators From The 1 Hour Timeframe

Trend Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bullish

Momentum Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Volatility Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bullish

Volume Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Strong Bearish

Trend Indicators (14)
  1. IndicatorValueSignal
  2. SMA 102336.74Bullish
  3. SMA 202305.45Bullish
  4. SMA 502286.17Bullish
  5. EMA 102333.93Bullish
  6. EMA 202316.14Bullish
  7. EMA 502293.70Bullish
  8. DEMA 102354.01Bearish
  9. DEMA 202341.77Bullish
  10. DEMA 502314.03Bullish
  11. TEMA 102356.97Bearish
  12. TEMA 202354.70Bearish
  13. TEMA 502329.33Bullish
  14. MACD20.46Bullish
  15. ADX31.86Strong Trend
Momentum Indicators (7)
  1. IndicatorValueSignal
  2. RSI78.60Overbought
  3. CCI103.90Overbought
  4. ROC 91.17Bullish
  5. ROC 143.40Bullish
  6. ROC 253.72Bullish
  7. Stoch K94.01Overbought
  8. Stoch D92.05Overbought
Volatility Indicators (4)
  1. IndicatorValueSignal
  2. BB Upper2373.17Neutral
  3. BB Middle2305.45Neutral
  4. BB Lower2237.73Neutral
  5. ATR14.54Low Volatility
Volume Indicators (1)
  1. IndicatorValueSignal
  2. MFI80.99Overbought

Overall Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bullish

Market Sentiment

Analysis Driven By 26 Technical Indicators From The 2 Hours Timeframe

Trend Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Strong Bullish

Momentum Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Volatility Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bullish

Volume Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Strong Bearish

Trend Indicators (14)
  1. IndicatorValueSignal
  2. SMA 102316.26Bullish
  3. SMA 202292.68Bullish
  4. SMA 502276.03Bullish
  5. EMA 102323.03Bullish
  6. EMA 202303.96Bullish
  7. EMA 502285.23Bullish
  8. DEMA 102348.35Bullish
  9. DEMA 202328.43Bullish
  10. DEMA 502297.57Bullish
  11. TEMA 102358.63Bearish
  12. TEMA 202343.47Bullish
  13. TEMA 502314.89Bullish
  14. MACD20.39Bullish
  15. ADX20.99Weak Trend
Momentum Indicators (7)
  1. IndicatorValueSignal
  2. RSI74.57Overbought
  3. CCI150.08Overbought
  4. ROC 93.86Bullish
  5. ROC 144.23Bullish
  6. ROC 253.45Bullish
  7. Stoch K95.05Overbought
  8. Stoch D91.83Overbought
Volatility Indicators (4)
  1. IndicatorValueSignal
  2. BB Upper2357.61Neutral
  3. BB Middle2292.68Neutral
  4. BB Lower2227.75Neutral
  5. ATR19.19Low Volatility
Volume Indicators (1)
  1. IndicatorValueSignal
  2. MFI84.62Overbought

Overall Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bullish

Market Sentiment

Analysis Driven By 26 Technical Indicators From The 4 Hours Timeframe

Trend Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Strong Bullish

Momentum Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Volatility Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Volume Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Strong Bearish

Trend Indicators (14)
  1. IndicatorValueSignal
  2. SMA 102292.92Bullish
  3. SMA 202281.13Bullish
  4. SMA 502273.22Bullish
  5. EMA 102305.27Bullish
  6. EMA 202289.54Bullish
  7. EMA 502283.11Bullish
  8. DEMA 102329.04Bullish
  9. DEMA 202306.41Bullish
  10. DEMA 502278.02Bullish
  11. TEMA 102342.97Bullish
  12. TEMA 202322.94Bullish
  13. TEMA 50N/AN/A
  14. MACD15.01Bullish
  15. ADX14.03Weak Trend
Momentum Indicators (7)
  1. IndicatorValueSignal
  2. RSI66.88Neutral
  3. CCI239.55Overbought
  4. ROC 93.27Bullish
  5. ROC 144.64Bullish
  6. ROC 254.77Bullish
  7. Stoch K93.24Overbought
  8. Stoch D86.87Overbought
Volatility Indicators (4)
  1. IndicatorValueSignal
  2. BB Upper2337.82Overbought
  3. BB Middle2281.13Neutral
  4. BB Lower2224.44Neutral
  5. ATR29.05Low Volatility
Volume Indicators (1)
  1. IndicatorValueSignal
  2. MFI81.39Overbought

Overall Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bullish

Market Sentiment

Analysis Driven By 33 Technical Indicators From The 1 Day Timeframe

Trend Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Strong Bullish

Momentum Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Volatility Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bearish

Volume Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Trend Indicators (22)
  1. IndicatorValueSignal
  2. SMA 102283.41Bullish
  3. SMA 202275.23Bullish
  4. SMA 502298.00Bullish
  5. SMA 1002275.43Bullish
  6. SMA 2002152.45Bullish
  7. EMA 102294.13Bullish
  8. EMA 202285.84Bullish
  9. EMA 502284.66Bullish
  10. EMA 1002255.42Bullish
  11. EMA 2002186.69Bullish
  12. DEMA 102312.38Bullish
  13. DEMA 202288.64Bullish
  14. DEMA 502297.81Bullish
  15. DEMA 1002328.72Bullish
  16. DEMA 2002309.62Bullish
  17. TEMA 102328.43Bullish
  18. TEMA 202300.81Bullish
  19. TEMA 502274.04Bullish
  20. TEMA 1002322.03Bullish
  21. TEMA 2002325.02Bullish
  22. MACD5.01Bullish
  23. ADX11.30Weak Trend
Momentum Indicators (6)
  1. IndicatorValueSignal
  2. RSI62.62Neutral
  3. CCI282.32Overbought
  4. ROC 143.92Bullish
  5. ROC 254.14Bullish
  6. Stoch K82.70Overbought
  7. Stoch D72.82Neutral
Volatility Indicators (4)
  1. IndicatorValueSignal
  2. BB Upper2324.71Overbought
  3. BB Middle2275.23Neutral
  4. BB Lower2225.75Neutral
  5. ATR45.02High Volatility
Volume Indicators (1)
  1. IndicatorValueSignal
  2. MFI65.00Neutral

Overall Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Market Sentiment

Analysis Driven By 21 Technical Indicators From The 1 Week Timeframe

Trend Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bearish

Momentum Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Volatility Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bullish

Volume Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Trend Indicators (10)
  1. IndicatorValueSignal
  2. SMA 202282.37Bullish
  3. SMA 502118.90Bullish
  4. EMA 202261.94Bullish
  5. EMA 502164.42Bullish
  6. DEMA 202330.00Bearish
  7. DEMA 502307.88Bearish
  8. TEMA 202320.75Bearish
  9. TEMA 502308.77Bearish
  10. MACD45.79Bearish
  11. ADX13.50Weak Trend
Momentum Indicators (6)
  1. IndicatorValueSignal
  2. RSI57.16Neutral
  3. CCI78.19Neutral
  4. ROC 14-2.15Bearish
  5. ROC 257.88Bullish
  6. Stoch K32.77Neutral
  7. Stoch D32.50Neutral
Volatility Indicators (4)
  1. IndicatorValueSignal
  2. BB Upper2400.06Neutral
  3. BB Middle2282.37Neutral
  4. BB Lower2164.68Neutral
  5. ATR99.98Low Volatility
Volume Indicators (1)
  1. IndicatorValueSignal
  2. MFI51.14Neutral

Overall Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Market Sentiment

Analysis Driven By 25 Technical Indicators From The 1 Month Timeframe

Trend Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Momentum Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bullish

Volatility Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bearish

Volume Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Trend Indicators (14)
  1. IndicatorValueSignal
  2. SMA 62241.83Bullish
  3. SMA 122097.50Bullish
  4. SMA 242074.76Bullish
  5. EMA 62231.47Bullish
  6. EMA 122149.62Bullish
  7. EMA 241988.61Bullish
  8. DEMA 62310.30Bearish
  9. DEMA 122288.01Bearish
  10. DEMA 242307.35Bearish
  11. TEMA 62318.64Bearish
  12. TEMA 122286.54Bearish
  13. TEMA 242320.58Bearish
  14. MACD349.67Bullish
  15. ADX39.14Strong Trend
Momentum Indicators (6)
  1. IndicatorValueSignal
  2. RSI64.27Neutral
  3. CCI97.35Neutral
  4. ROC 2537.78Bullish
  5. ROC 50203.55Bullish
  6. Stoch K69.30Neutral
  7. Stoch D75.56Neutral
Volatility Indicators (4)
  1. IndicatorValueSignal
  2. BB Upper2391.36Neutral
  3. BB Middle2091.49Neutral
  4. BB Lower1791.61Neutral
  5. ATR195.33High Volatility
Volume Indicators (1)
  1. IndicatorValueSignal
  2. MFI55.41Neutral